318 related articles for article (PubMed ID: 21540646)
21. What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?
Alexander MR; Ringe R; Sanders RW; Voss JE; Moore JP; Klasse PJ
J Virol; 2015 Jun; 89(11):5981-95. PubMed ID: 25810537
[TBL] [Abstract][Full Text] [Related]
22. Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design.
Andrabi R; Voss JE; Liang CH; Briney B; McCoy LE; Wu CY; Wong CH; Poignard P; Burton DR
Immunity; 2015 Nov; 43(5):959-73. PubMed ID: 26588781
[TBL] [Abstract][Full Text] [Related]
23. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
[TBL] [Abstract][Full Text] [Related]
24. Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice.
Dosenovic P; von Boehmer L; Escolano A; Jardine J; Freund NT; Gitlin AD; McGuire AT; Kulp DW; Oliveira T; Scharf L; Pietzsch J; Gray MD; Cupo A; van Gils MJ; Yao KH; Liu C; Gazumyan A; Seaman MS; Björkman PJ; Sanders RW; Moore JP; Stamatatos L; Schief WR; Nussenzweig MC
Cell; 2015 Jun; 161(7):1505-15. PubMed ID: 26091035
[TBL] [Abstract][Full Text] [Related]
25. VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA.
Jia M; Liberatore RA; Guo Y; Chan KW; Pan R; Lu H; Waltari E; Mittler E; Chandran K; Finzi A; Kaufmann DE; Seaman MS; Ho DD; Shapiro L; Sheng Z; Kong XP; Bieniasz PD; Wu X
Cell Host Microbe; 2020 Jun; 27(6):963-975.e5. PubMed ID: 32315598
[TBL] [Abstract][Full Text] [Related]
26. Germlining of the HIV-1 broadly neutralizing antibody domain m36.
Chen W; Li W; Ying T; Wang Y; Feng Y; Dimitrov DS
Antiviral Res; 2015 Apr; 116():62-6. PubMed ID: 25676867
[TBL] [Abstract][Full Text] [Related]
27. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC
PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908
[TBL] [Abstract][Full Text] [Related]
28. Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers.
Sliepen K; Medina-Ramírez M; Yasmeen A; Moore JP; Klasse PJ; Sanders RW
Virology; 2015 Dec; 486():116-20. PubMed ID: 26433050
[TBL] [Abstract][Full Text] [Related]
29. Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope.
Doores KJ; Kong L; Krumm SA; Le KM; Sok D; Laserson U; Garces F; Poignard P; Wilson IA; Burton DR
J Virol; 2015 Jan; 89(2):1105-18. PubMed ID: 25378488
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
Reh L; Magnus C; Kadelka C; Kühnert D; Uhr T; Weber J; Morris L; Moore PL; Trkola A
PLoS Pathog; 2018 Jan; 14(1):e1006825. PubMed ID: 29370298
[TBL] [Abstract][Full Text] [Related]
31. Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens.
Chen W; Streaker ED; Russ DE; Feng Y; Prabakaran P; Dimitrov DS
Biochem Biophys Res Commun; 2012 Jan; 417(4):1164-9. PubMed ID: 22226962
[TBL] [Abstract][Full Text] [Related]
32. Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.
Hwang JK; Wang C; Du Z; Meyers RM; Kepler TB; Neuberg D; Kwong PD; Mascola JR; Joyce MG; Bonsignori M; Haynes BF; Yeap LS; Alt FW
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8614-8619. PubMed ID: 28747530
[TBL] [Abstract][Full Text] [Related]
33. Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.
Strokappe N; Szynol A; Aasa-Chapman M; Gorlani A; Forsman Quigley A; Hulsik DL; Chen L; Weiss R; de Haard H; Verrips T
PLoS One; 2012; 7(3):e33298. PubMed ID: 22438910
[TBL] [Abstract][Full Text] [Related]
34. HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.
McGuire AT; Dreyer AM; Carbonetti S; Lippy A; Glenn J; Scheid JF; Mouquet H; Stamatatos L
Science; 2014 Dec; 346(6215):1380-1383. PubMed ID: 25504724
[TBL] [Abstract][Full Text] [Related]
35. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
Wu X; Zhou T; Zhu J; Zhang B; Georgiev I; Wang C; Chen X; Longo NS; Louder M; McKee K; O'Dell S; Perfetto S; Schmidt SD; Shi W; Wu L; Yang Y; Yang ZY; Yang Z; Zhang Z; Bonsignori M; Crump JA; Kapiga SH; Sam NE; Haynes BF; Simek M; Burton DR; Koff WC; Doria-Rose NA; Connors M; ; Mullikin JC; Nabel GJ; Roederer M; Shapiro L; Kwong PD; Mascola JR
Science; 2011 Sep; 333(6049):1593-602. PubMed ID: 21835983
[TBL] [Abstract][Full Text] [Related]
36. The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage.
Zhou JO; Zaidi HA; Ton T; Fera D
Front Immunol; 2020; 11():1529. PubMed ID: 32765530
[TBL] [Abstract][Full Text] [Related]
37. Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans.
Wu NR; Nicely NI; Lee EM; Reed RK; Watts BE; Cai F; Walkowicz WE; Aussedat B; Jones JA; Eaton A; Trama AM; Alam SM; Montefiori DC; Haynes BF; Saunders KO
PLoS Pathog; 2019 Dec; 15(12):e1008165. PubMed ID: 31841553
[TBL] [Abstract][Full Text] [Related]
38. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842
[TBL] [Abstract][Full Text] [Related]
39. Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.
Zhang Y; Chapman JH; Ulcay A; Sutton RE
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518644
[TBL] [Abstract][Full Text] [Related]
40. Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection.
Derdeyn CA; Moore PL; Morris L
Curr Opin HIV AIDS; 2014 May; 9(3):210-6. PubMed ID: 24662931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
